Suchergebnisse - "Ramanan, Athimalaipet V."

PubPharm (26)

1

Clinical effectiveness and safety of baricitinib for the treatment of juvenile idiopathic arthritis-associated uveitis or chronic anterior antinuclear antibody-positive uveitis : study protocol for an open-label, adalimumab active-controlled phase 3 clinical trial (JUVE-BRIGHT)

enthalten in: Trials | 2021

von Ramanan, A. | Guly, C. | Keller, S. | +4

2

Clinical effectiveness and safety of baricitinib for the treatment of juvenile idiopathic arthritis-associated uveitis or chronic anterior antinuclear antibody-positive uveitis: study protocol for an open-label, adalimumab active-controlled phase 3 clinical trial (JUVE-BRIGHT)

enthalten in: Trials | 2021

von Ramanan, A. | Guly, C. | Keller, S. | +4

3

"Environmental risk factors associated with juvenile idiopathic arthritis associated uveitis : a systematic review of the literature"

enthalten in: Journal of ophthalmic inflammation and infection | 2021

von Clarke, S. | Mageean, K. | Carlton, H. | +4

4

“Environmental risk factors associated with juvenile idiopathic arthritis associated uveitis: a systematic review of the literature”

enthalten in: Journal of ophthalmic inflammation and infection | 2021

von Clarke, S. | Mageean, K. | Carlton, H. | +4

5

“Environmental risk factors associated with juvenile idiopathic arthritis associated uveitis: a systematic review of the literature”

enthalten in: Journal of ophthalmic inflammation and infection | 2021

von Clarke, S. | Mageean, K. | Carlton, H. | +4

6

Discontinuing adalimumab in patients with controlled juvenile idiopathic arthritis-associated uveitis (ADJUST-Adalimumab in Juvenile Idiopathic Arthritis-associated Uveitis Stopping Trial) : study protocol for a randomised controlled trial

enthalten in: Trials | 2020

von Acharya, N. | Ebert, C. | Kelly, N. | +43

7

Discontinuing adalimumab in patients with controlled juvenile idiopathic arthritis-associated uveitis (ADJUST—Adalimumab in Juvenile Idiopathic Arthritis-associated Uveitis Stopping Trial): study protocol for a randomised controlled trial

enthalten in: Trials | 2020

von Acharya, N. | Ebert, C. | Kelly, N. | +3

8

Discontinuing adalimumab in patients with controlled juvenile idiopathic arthritis-associated uveitis (ADJUST—Adalimumab in Juvenile Idiopathic Arthritis-associated Uveitis Stopping Trial): study protocol for a randomised controlled trial

enthalten in: Trials | 2020

von Acharya, N. | Ebert, C. | Kelly, N. | +3

9

Same but different? A thematic analysis on adalimumab biosimilar switching among patients with juvenile idiopathic arthritis

enthalten in: Pediatric rheumatology online journal | 2019

von Renton, W. | Leveret, H. | Guly, C. | +3

10

Same but different? A thematic analysis on adalimumab biosimilar switching among patients with juvenile idiopathic arthritis

enthalten in: Pediatric rheumatology | 2019

von Renton, W. | Leveret, H. | Guly, C. | +3